Adjuvant treatment of severe acute pancreatitis with C1 esterase inhibitor concentrate after haematopoietic stem cell transplantation

Gut

Volumn 45, Issue 5, 1999, Pages 733-736

  Schneider, D T ^a,b   Nurnberger W ^a   Stannigel, H ^a   Bonig H ^a   Gobel U ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Acute pancreatitis; C1 esterase inhibitor; Capillary leakage syndrome; Complement system; Kallikrein bradykinin system

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR;

ACUTE PANCREATITIS; ARTICLE; CAPILLARY LEAK SYNDROME; CASE REPORT; CHILD; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; DRUG EFFICACY; DRUG SCREENING; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0032716925     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.5.733     Document Type: Article

References (17)

1. Blackberg M, Ohlsson K. Studies on the release of tissue kallikrein in experimental pancreatitis in the pig. Eur Surg Res 1994;26:116-24.
2. Yamaguchi H, Weidenbach H, Luhrs H, et al. Combined treatment with C1 esterase inhibitor and antithrombin III improves survival in severe acute experimental pancreatitis. Gut 1997;40:531-5.
3. Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokines new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993;40:522-30.
4. Lasson A, Ohlsson K. Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis. Thromb Res 1986;41:167-83.
5. Lasson A, Laurell AB, Ohlsson K. Correlation among complement activation, protease inhibitors, and clinical course in acute pancreatitis in man. Scand J Gastroenterol 1985;20:335-45.
6. Letch MM, Weidenbach H, Gress TM, et al. Effect of kinin inhibition in experimental acute pancreatitis. Am J Physiol 1995;269:G490-9.
7. Nürnberger W, Heying R, Burdach S, et al. C1 esterase inhibitor concentrate for capillary leakage syndrome following bone marrow transplantation. Ann Hematol 1997;75:95-101.
8. Shore T, Bow E, Greenberg H, et al. Pancreatitis post-bone marrow transplantation. Bone Marrow Transplant 1996;17:1181-4.
9. Werlin SL, Casper J, Antonson D, et al. Pancreatitis associated with bone marrow transplantation in children. Bone Marrow Tansplant 1992;10:65-9.
10. Ko CW, Gooley T, Schoch HG, et al. Acute pancreatitis in marrow transplant patients:prevalence at autopsy and risk factor analysis. Bone Morrow Transplant 1997;20:1081-6.
11. Jacobson AF, Teefey SA, Lee SP, et al. Frequent occurrence of new hepatobiliary abnormalities after bone marrow transplantation: results of a prospective study using scintigraphy and sonography. Am J Gastroenterol 1993;88:1044-9.
12. Ko CW, Murakami C, Sekijima JH, et al. Chemical composition of gallbladder sludge in patients after marrow transplantation. Am J Gastroenterol 1996;91:1207-10.
13. Acioli JM, Isobe M, Kawasaki S. Early complement system activation and neutrophil priming in acute pancreatitis: participation of trypsin. Surgery 1997;122:909-17.
14. Kald B, Kald A, Ihse I, et al. Release of platelet-activating factor in acute experimental pancreatitis. Pancreas 1993;8:410-2.
15. Lium B, Ruud TE, Pillgram-Larsen J, et al. Sodium taurocholate-induced acute pancreatitis in pigs. Pathomorphological studies of the pancreas in untreated animals and animals pretreated with high doses of corticosteroids or protease inhibitors. Acta Pathologica Microbiologica Immunologica Scandinavica [A] 1987;95:377-82.
16. Ruud TE, Aasen AO, Pillgram-Larsen J, et al. Effects on peritoneal proteolysis and hemodynamics of prophylactic infusion with C1 inhibitor in experimental acute pancreatitis. Scand J Gastroenterol 1986;21:1018-24.
17. Hazelzet JA, de Groot R, van Mierlo G, et al. Complement activation in relation to capillary leakage in children with septic shock and purpura. Infect Immun 1998;66:5350-6.